Literature DB >> 7616130

Quantification of apolipoproteins B-100, B-48, and E in human triglyceride-rich lipoproteins.

L Kotite1, N Bergeron, R J Havel.   

Abstract

We have developed a procedure to quantify apolipoprotein (apo) B-100, apoB-48, and apoE in human triglyceride-rich lipoproteins. This procedure permits delipidation of small amounts of triglyceride-rich lipoproteins without appreciable losses, and quantification of these apolipoproteins in samples containing as little as 10 micrograms of protein. Delipidated triglyceride-rich lipoproteins are subjected to sodium dodecyl sulfate polyacrylamide slab gel electrophoresis, and the mass of apolipoproteins is estimated after densitometric scanning and volume integration of Coomassie blue-stained bands. The chromogenicities of apoB-100 and apoB-48 are virtually identical, and twofold lower than that of apoE. The standard curve for each apolipoprotein follows a power function over a wide protein range, permitting quantification of as little as 0.2 microgram of apoB-48 and as much as 30 micrograms of apoB-100 from a single application of triglyceride-rich lipoproteins to the gels. This method is suitable for routine use in studies of the intestinal and hepatic contributions to triglyceride-rich lipoproteins and their responses to postprandial lipemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7616130

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  Plasma PCSK9 correlates with apoB-48-containing triglyceride-rich lipoprotein production in men with insulin resistance.

Authors:  Jean-Philippe Drouin-Chartier; André J Tremblay; Jean-Charles Hogue; Valéry Lemelin; Benoît Lamarche; Patrick Couture
Journal:  J Lipid Res       Date:  2018-06-26       Impact factor: 5.922

2.  Comparison of diets high in monounsaturated versus polyunsaturated fatty acid on postprandial lipoproteins in diabetes.

Authors:  C Madigan; M Ryan; D Owens; P Collins; G H Tomkin
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

3.  Protocol for the measurement of fatty acid and glycerol turnover in vivo in baboons.

Authors:  Raul A Bastarrachea; Sonya M Veron; Vidya Vaidyanathan; Maggie Garcia-Forey; V Saroja Voruganti; Paul B Higgins; Elizabeth J Parks
Journal:  J Lipid Res       Date:  2011-03-17       Impact factor: 5.922

4.  Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.

Authors:  V Atger; M de la Llera Moya; M Bamberger; O Francone; P Cosgrove; A Tall; A Walsh; N Moatti; G Rothblat
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

5.  Initial hepatic removal of chylomicron remnants is unaffected but endocytosis is delayed in mice lacking the low density lipoprotein receptor.

Authors:  J Herz; S Q Qiu; A Oesterle; H V DeSilva; S Shafi; R J Havel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

6.  High-carbohydrate diets affect the size and composition of plasma lipoproteins in hamsters (Mesocricetus auratus).

Authors:  Limin Wang; Jun Yu; Rosemary L Walzem
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

7.  Dietary sugars stimulate fatty acid synthesis in adults.

Authors:  Elizabeth J Parks; Lauren E Skokan; Maureen T Timlin; Carlus S Dingfelder
Journal:  J Nutr       Date:  2008-06       Impact factor: 4.798

8.  Prolonged postprandial responses of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein epsilon 4 allele.

Authors:  N Bergeron; R J Havel
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

9.  Key intestinal genes involved in lipoprotein metabolism are downregulated in dyslipidemic men with insulin resistance.

Authors:  Patrick Couture; André J Tremblay; Isabelle Kelly; Valéry Lemelin; Arnaud Droit; Benoît Lamarche
Journal:  J Lipid Res       Date:  2013-10-18       Impact factor: 5.922

10.  Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E.

Authors:  J Osuga; M Yonemoto; N Yamada; H Shimano; H Yagyu; K Ohashi; K Harada; T Kamei; Y Yazaki; S Ishibashi
Journal:  J Clin Invest       Date:  1998-07-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.